SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-153903
Filing Date
2016-11-02
Accepted
2016-11-02 06:45:14
Documents
3
Period of Report
2016-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-20816_18k.htm 8-K 23880
2 EX-99.1 a16-20816_1ex99d1.htm EX-99.1 105914
3 GRAPHIC g208161mm01i001.jpg GRAPHIC 2965
  Complete submission text file 0001104659-16-153903.txt   135141
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 161966250
SIC: 2834 Pharmaceutical Preparations